fda bpc-157 category 2 bulk drug substances list has removed certain that were placed on the two and has announced it will consult the Pharmacy Compounding Advisory Committee (PCAC) for potential future inclusion of This Isn't Really About BPC-157:

The peptides ability to enhance collagen production and organization directly addresses the disorganized tendon structure characteristic of tendinopathy

Beyond its effects on the central nervous system, DSIP has been detected in peripheral organs, blood, cerebrospinal fluid, and even human breast milk, indicating a systemic physiological role

The results are not directly comparable to systemic Thymosin Beta-4 or TB-500 administration Key distinction: TB-500 is a synthetic fragment designed to mimic aspects of Thymosin Beta-4

Some patients may need additional evaluation or labs depending on symptoms, history, and the clinician's judgment